Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Drug repositioning and repurposing for Alzheimer disease
Research on Melanotan 1 has focused on its usefulness in treating disorders such as erythropoietic protoporphyria (EPP), a condition causing heightened sensitivity to sunlight, and vitiligo, characterised by uneven skin pigmentation
He describes it as a novel glucagonGLP-1 dual agonist with the potential to reduce liver fat, decrease harmful visceral fat, and help preserve lean muscle mass, possibly in ways that differ from current therapies
Radiofrequency and ultrasound skin tightening treatments can enhance results, especially in areas with skin laxity
